HIGHLIGHTS
- who: Linda Rossi-Semerano from the University of Paris Sud, CHU de Rue du Général Leclerc, Le, France have published the Article: Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey, in the Journal: (JOURNAL)
- what: The authors aimed to estimate the off-label use of anti-IL-1 treatments in France assess their efficacy in rare diseases and increase the reporting of their possible side effects. The aims of the study were to 1) describe and analyse the efficacy and safety of anti-IL-1 agents . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.